Press Releases
Pacgen Enters into Agreement with General Biologicals Corporation
Pacgen to exhibit at the AMP 2012 Annual Meeting in Long Beach, California
Pacgen Enters Into Exclusive Distribution Agreement With Arise Biotech Corporation
Pacgen Announces Private Placement Financing and Financial Restructuring
Pacgen Signs Share Purchase Agreement to Acquire Xphase Pharmaceuticals
Pacgen Announces Second Closing of Private Placement Financing
Pacgen Announces First Closing of Private Placement Financing
Pacgen Announces Positive Results from Phase IIb Dose-Ranging Trial of PAC-113
Pacgen Completes Patient Recruitment for Phase II Dose Ranging Trial of Novel Anti-Fungal Drug
Pacgen to Present at the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference
Pacgen Announces Positive Results from Phase I/II Trial of Novel Anti-Fungal Drug.
Pacgen Builds on New Leadership and Updates Options Outstanding
Pacgen Completes Patient Recruitment for Phase I/II Trial of Novel Anti-Fungal Drug
Pacgen Reports Third Quarter Financial and Operating Results
Pacgen Biopharmaceuticals Names Dr. Alan Moore and Mr. Kevin McGarry to the Board of Directors
Pacgen Biopharmaceuticals Appoints Christina Yip as Chief Financial Officer
Pacgen Biopharmaceuticals In-Licenses Compounds for Oral Diseases from Demegen